FDA Approved Medical Products for:

Acute intermittent porphyria

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Hemin
Trade Name
(Manufacturer Name)
Panhematin®
(Lundbeck Inc.)
Indication
The FDA has approved this product to be used in this manner.
Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria.
More Information about this product Drug Information Portal